Bixiye
QP71-23 Register for Webinar | Trauma-Informed Care 102 | Tuesday, September 28, 5-6:30 pm
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Natiijooyinka Raadinta
Soo bandhiga 2261 - 2270 ee natiijooyinka 4128
Bixiye
QP72-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2023
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP73-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2023
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP74-23 Commercial Pharmacy Benefit Exclusion for Abilify Asimtufii®, Adstiladrin®, Brixadi™, Glydo®, lidocaine 2%, Roctavian™, and Uzedy™
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP75-23 MHCP Pharmacy Benefit Exclusion for Adstiladrin®, Brixadi™, and Roctavian™
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP76-23 Commercial Pharmacy Benefit Exclusion for Sublocade®
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
P59-23 Services Removed from the Commercial Prior Authorization List
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2023
Bixiye
P60-23 Home Health Agencies are Required to Provide Minnesota Home Care Bill of Rights for Clients
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2023
Bixiye
P61-23 Inpatient Hospital Admission Prior Authorization Removed for Medicare Advantage; Pre-Admission Notification Required
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2023
Bixiye
P62-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2023